文献速递外周血管泌尿生殖技术与安全USDSACT

超声造影对慢性肾病患者肾动脉狭窄诊断与随访的价值

Value of contrast-enhanced ultrasound for diagnosis and follow-up of renal artery stenosis in patients with chronic kidney disease.
PubMed 文献 · Abdom Radiol (NY) · 2022-03-05

前瞻性单中心研究纳入60例慢性肾病合并肾动脉狭窄患者,以DSA或CTA为金标准评估超声造影诊断肾动脉狭窄的敏感度94.7%、特异度84.0%、准确率92.5%。超声造影对CKD3b-5组与CKD1-3a组、大动脉炎性与动脉粥样硬化性肾动脉狭窄的诊断准确率无显著差异,并可用于支架内再狭窄或狭窄进展的随访。

要点

  • 超声造影诊断慢性肾病患者中重度肾动脉狭窄的敏感度94.7%、特异度84.0%、准确率92.5%。
  • 超声造影对CKD3b-5组与CKD1-3a组诊断准确率无显著差异(100% vs 87.5%,P=0.148)。
  • 超声造影可用于肾动脉血运重建术后支架内再狭窄或狭窄进展的随访监测。

核心结论

  • 超声造影检查是诊断慢性肾病患者中重度肾动脉狭窄的可信替代方法,也是肾动脉血运重建治疗后随访监测的可靠工具,不应被视为彩色多普勒超声的补救手段。

研究设计与样本

  • 前瞻性单中心研究,纳入肾动脉狭窄患者60例,平均年龄64.4±18.0岁,中位估算肾小球滤过率66.1 mL/min/1.73 m2;以数字减影血管造影或计算机断层血管造影为金标准,超声医师作为超声造影报告判读者并对DSA或CTA结果设盲。

诊断标准与关键数值

  • 超声造影诊断肾动脉狭窄的kappa值0.776(P<0.001),准确率92.5%,敏感度94.7%,特异度84.0%;超声造影检查94条狭窄肾动脉,DSA或CTA证实96条肾动脉存在狭窄。

临床应用与阅片要点

  • 超声造影对CKD1-3a组诊断准确率87.5% vs CKD3b-5组100%(P=0.148,无显著差异);对大动脉炎性肾动脉狭窄诊断准确率95.8% vs 动脉粥样硬化性肾动脉狭窄91.7%(P=0.795,无显著差异);29次超声造影检查用于随访支架内再狭窄或肾动脉狭窄进展,中位随访时间5.0个月(范围1.0-20.0),其中2例肾功能恶化并复发高血压患者的支架内再狭窄经超声造影检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate whether contrast-enhanced ultrasound (CEUS) is an accurate, non-nephrotoxic diagnostic method and follow-up tool for use in patients with chronic kidney disease (CKD) and renal artery stenosis (RAS).

METHODS: In this prospective and monocentric study, we compared the sensitivity and specificity of CEUS for the diagnosis of RAS in CKD patients, using digital subtraction angiography (DSA) or computed tomographic angiography (CTA) as the gold standard methods. Further, the value of CEUS for distinguishing restenosis from other diseases was assessed. The ultrasound physicians conducted the examinations and served as the CEUS report readers who were blinded to the DSA or CTA results.

RESULTS: Patients with RAS (n = 60) were enrolled. Average patient age was 64.4 ± 18.0 years and median estimated glomerular filtration rate was 66.1 mL/min/1.73 m2. CEUS was used to image 94 stenotic renal arteries and DSA- or CTA-verified stenosis was present in 96 renal arteries. The kappa value for CEUS was 0.776 (P < 0.001), with an accuracy of 92.5%, a sensitivity of 94.7%, and a specificity of 84.0%. The accuracy of CEUS was the same for the diagnosis of the CKD3b-5 group as for the CKD1-3a group (100% vs. 87.5%, P = 0.148). There was no difference in CEUS accuracy for the diagnosis of Takayasu RAS compared with atherosclerotic RAS (95.8% vs. 91.7%, P = 0.795). Twenty-nine CEUS examinations were performed to follow in-stent restenosis or progression of RAS, with a median follow-up time of 5.0 months (range 1.0-20.0). Two cases of in-stent restenosis in patients suffering from deteriorating kidney function and recurrent hypertension were examined by CEUS.

CONCLUSION: CEUS examination is a credible alternative for diagnosing moderate and severe RAS in patients with CKD, and is a reliable tool for follow-up surveillance after renal artery revascularization treatment. It shouldn't be thought as a color-coded duplex ultrasonography rescue in these patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Li, Mao, Zhao, et al. Value of contrast-enhanced ultrasound for diagnosis and follow-up of renal artery stenosis in patients with chronic kidney disease. Abdom Radiol (NY). 2022. PMID: 35247061. doi:10.1007/s00261-022-03457-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。